Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Protease Inhibitor Cocktail for Lysosome Research
2026-09-12
Protect lysosome-repair proteins and native complexes during extraction with an EDTA-free, broad-spectrum formulation. Its 100X DMSO format supports Western blotting, co-immunoprecipitation, phosphorylation analysis, and kinase workflows without intentionally chelating divalent cations.
-
Demethyleneberberine: Applied Research Workflows
2026-09-11
Demethyleneberberine (DMB) is a versatile research tool for inflammation, neurodegeneration, autoimmune hepatitis, and non-small cell lung cancer models. This workflow-focused guide connects concentration selection, pathway-aware assays, formulation control, and troubleshooting for more reproducible in vitro and in vivo studies.
-
Laminin (925-933) Assay Workflow Guide
2026-09-11
Laminin (925-933) is a defined Laminin B1 chain peptide for testing receptor-associated cell attachment, migration, and chemotaxis without the structural complexity of full-length laminin. This guide covers preparation, assay controls, and troubleshooting; the peptide is for in vitro research and should not be treated as a diagnostic, therapeutic, or broadly validated metastasis intervention.
-
Hematoxylin and Eosin Staining Kit Guide
2026-09-10
The Hematoxylin and Eosin Staining Kit provides ready-to-use solutions for consistent nuclear and cytoplasmic contrast in paraffin-embedded or frozen tissue sections and cytological preparations. It supports research-based tissue morphology visualization and cellular structure assessment, but is not intended for diagnostic, clinical, or medical use.
-
BHA in Translational Redox Research
2026-09-10
A strategic guide to using Butylated hydroxyanisole (BHA) as a controlled redox perturbation, while applying lessons from GnRH antagonist engineering to assay design, translational interpretation, and reproducibility.
-
Tioconazole Workflows for Antifungal Research
2026-09-09
Build more reproducible antifungal screens with Tioconazole by controlling solvent, dosing, incubation, and assay readouts. This guide connects its cytochrome P450 and ergosterol-focused mechanism with practical fungal infection model workflows while clearly separating validated product data from exploratory assay recommendations.
-
ALKBH5 Lactylation in Antiviral Innate Immunity
2026-09-09
The 2024 PNAS study identifies ALKBH5 lactylation as a regulatory switch that strengthens m6A-dependent IFN-β mRNA biogenesis during HSV-1, KSHV, and mpox virus infection. Its ESCO2–SIRT6 mechanism connects cellular lysine acylation with antiviral RNA regulation and provides a framework for dissecting infection-associated transcriptional stress.
-
CXCR4–EGFR Heteromers Reshape Signaling
2026-09-08
Comez et al. show that CXCR4 and EGFR assemble into signaling-competent oligomeric complexes whose conformation and Gi-protein coupling change with receptor stimulation. By combining NanoBRET with nanobody-based proximity ligation assays, the study connects receptor proximity in engineered cells with endogenous CXCR4–EGFR complexes in HeLa cells, providing a framework for interpreting receptor crosstalk in cancer biology.
-
EGCG Nanoparticles Sensitize Tumors to FLASH-RT
2026-09-08
Xu et al. developed functionalized self-assembled EGCG nanoparticles, termed BENPs, to increase tumor sensitivity to FLASH radiotherapy while strengthening antitumor immune responses. The study combines viability, DNA-damage, histological, flow-cytometric, cytokine, and transcriptomic analyses, providing a framework for linking radiosensitization with immune remodeling.
-
TGF-β, Sca-1, and Mammary Cell Plasticity
2026-09-07
The 2020 Scientific Reports study shows that TGF-β controls Sca-1 expression while reshaping lineage plasticity and tumor-initiating potential in pre-neoplastic and mammary cancer models. Its central contribution is the distinction between endogenous Smad2/3/4-dependent regulation and exogenous TGF-β-driven Sca-1 loss that can occur independently of Smad2/3, an important consideration for interpreting stem-cell markers and pathway inhibition experiments.
-
Partial BACE Inhibition Preserves Synaptic Transmission
2026-09-07
Satir et al. show that moderate β-secretase inhibition can reduce amyloid β secretion without disrupting synaptic transmission in primary cortical neuron cultures. The study defines an experimentally useful safety window for Aβ-lowering strategies while cautioning that stronger BACE inhibition may impair neuronal function.
-
Melatonin–Sacchachitin Hydrogel for Atopic Dermatitis
2026-09-05
The reference study developed a melatonin-loaded sacchachitin nanofiber hydrogel and evaluated it in a DNCB-induced NC/Nga mouse model of atopic dermatitis. Its main contribution is to combine a biocompatible structural scaffold with melatonin-driven anti-inflammatory activity, while preserving relevant hydrogel stability and mechanical properties.
-
Infigratinib Reverses ABCB1-Linked Drug Resistance
2026-09-04
The reference study shows that infigratinib (BGJ 398), a pan-FGFR inhibitor, can restore paclitaxel and doxorubicin sensitivity in ABCB1-overexpressing tumor cells by impairing drug efflux rather than reducing transporter expression. Its comparison with PD 173074 highlights that FGFR kinase inhibition and multidrug-resistance reversal are separable pharmacologic properties that require independent testing.
-
Triiodothyronine T3 Workflows for Adipose Research
2026-09-04
Build reproducible T3 experiments for thyroid hormone receptor activation, beige adipocyte thermogenesis, and cellular metabolism assays. This workflow distinguishes direct endocrine signaling from SETD7-driven adipose remodeling while providing practical preparation, dosing, and troubleshooting guidance.
-
gamma-Glu-Cys (γ-Glu-Cys) Lab Guide
2026-09-03
A scenario-based guide to using gamma-Glu-Cys (γ-Glu-Cys), SKU B7887, in glutathione metabolism research, glutathione synthetase enzyme assays, and carefully controlled cell experiments. It connects product specifications with practical controls, storage decisions, interpretation limits, and evidence from γ-glutamyl peptide research.